microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells
暂无分享,去创建一个
C. Miracco | S. Comincini | L. Pirtoli | S. Palumbo | G. Allavena | Martina Morini | F. Angeletti | Francesca Durando | Giulia Allavena | Silvia Palumbo
[1] S. Comincini,et al. Autophagy and ionizing radiation in tumors: The “survive or not survive” dilemma , 2013, Journal of cellular physiology.
[2] M. Detmar,et al. The miR-290-295 cluster suppresses autophagic cell death of melanoma cells , 2012, Scientific Reports.
[3] J. Park,et al. Silencing of MicroRNA-21 Confers Radio-Sensitivity through Inhibition of the PI3K/AKT Pathway and Enhancing Autophagy in Malignant Glioma Cell Lines , 2012, PloS one.
[4] L. Fassina,et al. AUTOCOUNTER, an ImageJ JavaScript to analyze LC3B-GFP expression dynamics in autophagy-induced astrocytoma cells , 2012, European journal of histochemistry : EJH.
[5] A. Tsung,et al. miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. , 2012, Gastroenterology.
[6] G. Cevenini,et al. Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments , 2012, Journal of cellular biochemistry.
[7] Bo Liu,et al. MicroRNA-modulated autophagic signaling networks in cancer. , 2012, The international journal of biochemistry & cell biology.
[8] J. Ju,et al. Inhibition of autophagy and tumor growth in colon cancer by miR-502 , 2012, Oncogene.
[9] C. Plass,et al. miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. , 2012, Cancer research.
[10] Robert Clarke,et al. Guidelines for the use and interpretation of assays for monitoring autophagy , 2012 .
[11] Jianzhen Xu,et al. MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis , 2012, Autophagy.
[12] M. Prescott,et al. The Intriguing Life of Autophagosomes , 2012, International journal of molecular sciences.
[13] Q. Zeng,et al. Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma. , 2012, The Biochemical journal.
[14] M. Guiou,et al. Novel Therapies in Glioblastoma , 2012, Neurology research international.
[15] P. Soares,et al. The mTOR Signalling Pathway in Human Cancer , 2012, International journal of molecular sciences.
[16] Feng-ping Huang,et al. TMZ‐induced PrPc/par‐4 interaction promotes the survival of human glioma cells , 2012, International journal of cancer.
[17] Yang Wang,et al. MicroRNA-30a Sensitizes Tumor Cells to cis-Platinum via Suppressing Beclin 1-mediated Autophagy* , 2011, The Journal of Biological Chemistry.
[18] A. Krogh,et al. microRNA‐101 is a potent inhibitor of autophagy , 2011, The EMBO journal.
[19] Yong Chen,et al. MicroRNA-Mediated Positive Feedback Loop and Optimized Bistable Switch in a Cancer Network Involving miR-17-92 , 2011, PloS one.
[20] Norbert Gretz,et al. miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes , 2011, J. Biomed. Informatics.
[21] G. Mazzini,et al. Silencing of cellular prion protein (PrPC) expression by DNA-antisense oligonucleotides induces autophagy-dependent cell death in glioma cells , 2011, Autophagy.
[22] Z. Elazar,et al. Biogenesis and cargo selectivity of autophagosomes. , 2011, Annual review of biochemistry.
[23] Ming Yi,et al. Human glioma growth is controlled by microRNA-10b. , 2011, Cancer research.
[24] Sujaya Srinivasan,et al. A Ten-microRNA Expression Signature Predicts Survival in Glioblastoma , 2011, PloS one.
[25] G. Velasco,et al. A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma , 2011, Molecular Cancer Therapeutics.
[26] Anjali J. Koppal,et al. Supplementary data: Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites , 2010 .
[27] Lin He,et al. mir-17-92, a cluster of miRNAs in the midst of the cancer network. , 2010, The international journal of biochemistry & cell biology.
[28] S. Fulda,et al. Therapeutic exploitation of apoptosis and autophagy for glioblastoma. , 2010, Anti-cancer agents in medicinal chemistry.
[29] W. Filipowicz,et al. Regulation of mRNA translation and stability by microRNAs. , 2010, Annual review of biochemistry.
[30] J. Grillari,et al. miR-17–92 cluster: ups and downs in cancer and aging , 2010, Biogerontology.
[31] K. Dalby,et al. Targeting the pro-death and pro-survival functions of autophagy as novel therapeutic strategies in cancer , 2010, Autophagy.
[32] S. S. Ajay,et al. Unified translation repression mechanism for microRNAs and upstream AUGs , 2010, BMC Genomics.
[33] K. Ryan,et al. The role of autophagy in tumour development and cancer therapy , 2009, Expert Reviews in Molecular Medicine.
[34] D. Klionsky,et al. Regulation mechanisms and signaling pathways of autophagy. , 2009, Annual review of genetics.
[35] Xiuping Liu,et al. Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells , 2009, Autophagy.
[36] Brian D Athey,et al. New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites. , 2009, Genome research.
[37] Zhenghong Qin,et al. The role of autophagy in sensitizing malignant glioma cells to radiation therapy. , 2009, Acta biochimica et biophysica Sinica.
[38] Avner Friedman,et al. MicroRNA regulation of a cancer network: Consequences of the feedback loops involving miR-17-92, E2F, and Myc , 2008, Proceedings of the National Academy of Sciences.
[39] C. Burge,et al. Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.
[40] S. Grimmond,et al. The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition , 2008, Genome Biology.
[41] Terry Hyslop,et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation , 2008, The Journal of cell biology.
[42] A. Donfrancesco,et al. Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM , 2008, PloS one.
[43] Guido Kroemer,et al. Autophagy in the Pathogenesis of Disease , 2008, Cell.
[44] R. Kiss,et al. Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. , 2007, The oncologist.
[45] J. Rossi. Transcriptional activation by small RNA duplexes. , 2007, Nature chemical biology.
[46] Anwar Hossain,et al. Mir-17-5p Regulates Breast Cancer Cell Proliferation by Inhibiting Translation of AIB1 mRNA , 2006, Molecular and Cellular Biology.
[47] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[48] Masaaki Komatsu,et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice , 2005, The Journal of cell biology.
[49] Peter F Stadler,et al. Molecular evolution of a microRNA cluster. , 2004, Journal of molecular biology.
[50] Hiroyuki Tagawa,et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. , 2004, Cancer research.
[51] I. Germano,et al. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells , 2004, Cell Death and Differentiation.
[52] G. Ruvkun,et al. A uniform system for microRNA annotation. , 2003, RNA.
[53] Takeshi Noda,et al. Tor, a Phosphatidylinositol Kinase Homologue, Controls Autophagy in Yeast* , 1998, The Journal of Biological Chemistry.
[54] R. Kiss,et al. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. , 2009, Advances and technical standards in neurosurgery.